Genetic variation in the transforming growth factor-β1 gene is associated with susceptibility to IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 24, Issue 10, 2009, Pages 3061-3067

  Vuong, Mai Tuyet ^a,b,c   Lundberg, Sigrid ^d   Gunnarsson, Iva ^a   Wramner, Lars ^e   Seddighzadeh, Maria ^a   Hahn Zoric, Mirjana ^e   Fernström, Anders ^f   Hanson, Lars A ^e   Do, Lieu Thi ^c   Jacobson, Stefan H ^b   Padyukov, Leonid ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c HANOI MEDICAL UNIVERSITY   (Viet Nam)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

IgA nephropathy; Polymorphism; SNP; TGFB1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA EXTRACTION; FEMALE; GENE; GENE FREQUENCY; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DETERMINATION; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

ADOLESCENT; ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 70349484209     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp079     Document Type: Article

References (35)

1. Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 1990; 89: 209-215
2. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000; 36: 227-237
3. Julian BA, Quiggins PA, Thompson JSet al. Familial IgA nephropathy. Evidence of an inherited mechanism of disease. N Engl J Med 1985; 312: 202-208
4. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002; 347: 738-748
5. Park SR, Lee JH, Kim PH. Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes. Eur J Immunol 2001; 31: 1706-1715
6. Border WA, Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest 1992; 90: 1-7
7. Border WA. Transforming growth factor-beta and the pathogenesis of glomerular diseases. Curr Opin Nephrol Hypertens 1994; 3: 54-58
8. Coll E, Cormand B, Campos B et al. Association of TGF-beta1 polymorphisms with chronic renal disease. J Nephrol 2004; 17: 794-799
9. Lim CS, Kim YS, Chae DW et al. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy. Clin Nephrol 2005; 63: 61-67
10. Sato F, Narita I, Goto S et al. Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy. Tissue Antigens 2004; 64: 35-42
11. Xaubet A, Marin-Arguedas A, Lario S et al. Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 431-435
12. Awad MR, El-Gamel A, Hasleton P et al. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibro-sis after lung transplantation. Transplantation 1998; 66: 1014-1020
13. Carturan S, Roccatello D, Menegatti E et al. Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy. J Nephrol 2004; 17: 786-793
14. Bantis C, Heering P, Aker S et al. Influence of cytokine gene polymorphisms on IgA nephropathy. Ren Fail 2008; 30: 135-140
15. Levey AS, Bosch JP, Lewis JB et al. Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
16. Padyukov L, Hahn-Zoric M, Blomqvist SR et al. Distribution of human kappa locus IGKV2-29 and IGKV2D-29 alleles in Swedish Caucasians and Hong Kong Chinese. Immunogenetics 2001; 53: 22-30
17. Wang B, Morinobu A, Kanagawa S et al. Transforming growth factor beta 1 gene polymorphism in Japanese patients with systemic lupus erythematosus. Kobe J Med Sci 2007; 53: 15-23
18. Barrett JC, Fry B, Maller J et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265
19. Bisceglia L, Cerullo G, Forabosco P et al. Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. Am J Hum Genet 2006; 79: 1130-1134
20. Gharavi AG, Yan Y, Scolari F et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 2000; 26: 354-357
21. Paterson AD, Liu XQ, Wang K et al. Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J Am Soc Nephrol 2007; 18: 2408-2415
22. Julian BA, Wyatt RJ, Matousovic K et al. IgA nephropathy: a clinical overview. Contrib Nephrol 2007; 157: 19-26
23. Akiyama F, Tanaka T, Yamada R et al. Single-nucleotide polymor-phismsinthe classII regionofthe major histocompatibility complex in Japanese patients with immunoglobulin a nephropathy. J Hum Genet 2002; 47: 532-538
24. Batra A, Smith AC, Feehally J et al. T-cell homing receptor expression in IgA nephropathy. Nephrol Dial Transplant 2007; 22: 2540-2548
25. Deenitchina SS, Shinozaki M, Hirano T et al. Association of a T-cell receptor constant alpha chain gene polymorphism with progression of IgA nephropathy in Japanese patients. Am J Kidney Dis 1999; 34: 279-288
26. Li PK, Poon P, Phil M et al. Association of IgA nephropathy with T-cell receptor constant alpha chain gene polymorphism. Am J Kidney Dis 1997; 30: 260-264
27. Matsunaga A, Numakura C, Kawakami T et al. Association of the uteroglobin gene polymorphism with IgA nephropathy. Am J Kidney Dis 2002; 39: 36-41
28. Shijubo N, Kawabata I, Sato N et al. Clinical aspects of Clara cell 10-kDa protein/uteroglobin (secretoglobin 1A1). Curr Pharm Des 2003; 9: 1139-1149
29. Coppo R, Amore A, Peruzzi L et al. Angiotensin antagonists and fish oil for treating IgA nephropathy. Contrib Nephrol 2007; 157: 27-36
30. Locatelli F, Vecchio LD, Pozzi C. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors. Nat Clin Pract Nephrol 2006; 2: 24-31
31. Maruyama K, Yoshida M, Nishio H et al. Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol 2001; 16: 350-355
32. Ong-Ajyooth S, Ong-Ajyooth L, Limmongkon A et al. The renin-angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy. J Med Assoc Thai 1999; 82: 681-689
33. Wada J, Sugiyama H, Makino H. Pathogenesis of IgA nephropathy. Semin Nephrol 2003; 23: 556-563
34. Watanabe Y, Kinoshita A, Yamada T et al. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway. J Hum Genet 2002; 47: 478-483
35. Ohtsuka T, Yamakage A, Yamazaki S. The polymorphism of transforming growth factor-beta1 gene in Japanese patients with systemic sclerosis. Br J Dermatol 2002; 147: 458-463